Regal Assets Analytics

SanaCurrents on Aadi Bio’s (AADI) expansion of nab-Sirolimus to solid tumor cancers

By |2023-01-23T08:59:08-05:00January 21st, 2023|Tags: |

Aadi Bioscience, Inc. (NASDAQ:AADI) Probability Sentiment SUMMARY Shortly after listing in mid-2021, Aadi Bioscience, Inc. [...]

SanaCurrents on Syndax’s (SNDX) rising drug to treat rare, acute leukemias

By |2023-01-17T08:26:57-05:00January 15th, 2023|Tags: |

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Probability Sentiment SUMMARY Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is advancing the small [...]

SanaCurrents on X4 Pharma’s (XFOR) small molecule to treat chronic neutropenia

By |2023-01-09T08:31:40-05:00January 7th, 2023|Tags: |

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Probability Sentiment SUMMARY X4 Pharmaceuticals, Inc.’s (NASDAQ:XFOR) mavorixafor posted impressive clinical [...]

SanaCurrents on PDUFA decision for Tarsus’ (TARS) drug to treat dry eye caused by mites

By |2022-12-19T10:11:18-05:00December 17th, 2022|Tags: |

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Probability Sentiment SUMMARY Staying focused on an FDA approval paid off [...]

SanaCurrents on Cyteir’s (CYT) push for CYT-0851 in Triple Negative Breast Cancer

By |2022-12-13T08:41:19-05:00December 10th, 2022|Tags: |

Cyteir Therapeutics, Inc. (NASDAQ:CYT) Probability Sentiment SUMMARY Cyteir Therapeutics (NASDAQ:CYT) listed in June 2021, raising [...]

SanaCurrents on Seres’ (MCRB) fast follower microbiome treatment to prevent recurrent C. difficile infection (rCDI)

By |2022-12-05T08:12:40-05:00December 3rd, 2022|Tags: |

Seres Therapeutics, Inc. (NASDAQ:MCRB) Probability Sentiment SUMMARY Research in human microbiome treatments picked up rapidly [...]

SanaCurrents on ReNovoRx’s (RNXT) drug-device treatment for pancreatic cancer

By |2022-11-22T14:35:55-05:00November 19th, 2022|Tags: |

Renovorx, Inc. (NASDAQ:RNXT) Probability Sentiment SUMMARY While pancreatic cancer has attracted many recent drug candidates [...]

SanaCurrents on Gossamer’s (GOSS) approach to treat pulmonary arterial hypertension (PAH)

By |2022-11-14T08:02:30-05:00November 12th, 2022|Tags: |

Gossamer Bio, Inc. (NASDAQ:GOSS) Probability Sentiment SUMMARY The condition known as pulmonary arterial hypertension (PAH) [...]

Go to Top